Ua sainia e le MGC Pharmaceuticals Ltd. se maliliega fa'asoa fa'atasi ma Sciensus Rare, o se vaega o le vaega o le soifua maloloina a Peretania, Sciensus, mo le tufatufaina atu o CannEpil® ma CogniCann® i teritori autu o Europa ma Peretania.
O le maliliega e mo le tufatufaina atu i teritori autu Europa ma Peretania mo CannEpil®, faʻaaogaina e togafitia ai le Epilepsy Resistant Drug, ma CogniCann®, faʻaaogaina e togafitia ai tagata mamaʻi e maua i le Dementia ma le faʻamaʻi o le Alzheimer.
Sciensus Rare ose kamupani fa'ava-o-malo fa'atauva'a fa'avae i Netherlands, fa'apitoa i le tu'uina atu o vaila'au fa'ama'i e le masani ai e ala i fa'ata'ita'iga fa'apitoa fa'apitoa ma polokalame fa'afoma'i vave, fa'atasi ai ma le 30-tausaga o le poto masani i le tu'uina atu o auaunaga tau soifua maloloina, ma fa'alauteleina avanoa fa'afoma'i mo oloa i totonu. Europa i Sisifo.
I lalo o tuutuuga o le tufatufaina atu, Sciensus Rare ua tofia e avea ma tufatufa faapitoa o CannEpil® ma CogniCann® i Tenimaka, Farani, Italia, Sepania, Luxembourg, ma le Malo Tele, o nisi o maketi tau vailaau sili ona maualuga i le lalolagi, mo se vaitaimi muamua e 4 tausaga. A maeʻa le 12 masina muamua o le maliega, Sciensus Rare o le a noatia i lalo ole faʻatauga manaʻomia e faʻamautu ai lona tulaga tufatufaina. Ua ioe Itu Pati o le MGC Pharma o le a faaauau pea ona nafa ma le sailia o le Maketi Faatagaina i totonu o nei teritori, ae o Sciensus Rare o le a nafa ma talosaga i Polokalame Early Access ma Named Patient Programmes.
Roby Zomer, Pule Sili ma Pule Sili o MGC Pharma, fai mai: "Sciensus Rare o se kamupani auaunaga tau vailaau sili ona lelei, faatasi ai ma le poto masani ma le tomai talafeagai e faateleina ai le avanoa mo le CannEpil® ma CogniCann® i na gasegase e sili ona manaʻomia.
O le isi lea laasaga taua i le faʻalauteleina o avanoa o tagata maʻi i a tatou vailaʻau, ma tuʻuina se fuafuaga umi e fausia ai fesoʻotaʻiga tufatufaina e manaʻomia i Europa i Sisifo, o se tasi o maketi tau vailaʻau sili ona taua i le lalolagi.
Gareth Williams, Peresitene o Sciensus Rare, fai mai: "Matou te matua fiafia lava e galulue faʻatasi ma MGC Pharmaceuticals i totonu o le maketi o le cannabis faʻafomaʻi faʻavaomalo ma tulimatai atu i le lagolagoina o fomaʻi e mafai ona maua uma CannEpil® ma CogniCann®."
OA MEA E AVEA MAI LENEI TUSI:
- Under the terms of the distribution agreement, Sciensus Rare has been appointed the exclusive distributor of CannEpil® and CogniCann® in Denmark, France, Italy, Spain, Luxembourg, and the United Kingdom, some of the most advanced pharmaceutical markets in the world, for an initial 4-year term.
- Sciensus Rare ose kamupani fa'ava-o-malo fa'atauva'a fa'avae i Netherlands, fa'apitoa i le tu'uina atu o vaila'au fa'ama'i e le masani ai e ala i fa'ata'ita'iga fa'apitoa fa'apitoa ma polokalame fa'afoma'i vave, fa'atasi ai ma le 30-tausaga o le poto masani i le tu'uina atu o auaunaga tau soifua maloloina, ma fa'alauteleina avanoa fa'afoma'i mo oloa i totonu. Europa i Sisifo.
- This is another important step in widening patient access to our pharmaceutical products, and puts in place a long term plan to build the distribution networks required in Western Europe, one of the most important pharmaceutical markets in the world.
